Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Goi

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Oncology Reports|May 19, 2011
Significance of tumor marker SLX in colorectal cancerA Yamaguchi, T Goi, N Ohtaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patientsA Yamaguchi, T Urano, T Goi, et al.
The Journal of Hospital Infection|January 12, 2010
Effect of anaesthesia maintained with sevoflurane and propofol on surgical site infection after elective open gastrointestinal surgeryK Shimizu, M Hirose, S Mikami, et al.
Journal of Gastroenterology|July 11, 1998
Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancerA Yamaguchi, T Goi, S Taguchi, et al.
Gynecologic Oncology|January 1, 1997
The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancerK Shimabukuro, N Toyama-Sorimachi, Y Ozaki, et al.
Oncology Reports|May 25, 2011
Sialyl-lewis-x antigen immunoreaction of colorectal-cancer and its relationship to hematogenous metastasisA Yamaguchi, M Saitoh, T Goi, et al.
Oncology|September 10, 1998
Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resectionA Yamaguchi, T Goi, K Seki, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Oncology Reports|May 19, 2011
Significance of tumor marker SLX in colorectal cancerA Yamaguchi, T Goi, N Ohtaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patientsA Yamaguchi, T Urano, T Goi, et al.
The Journal of Hospital Infection|January 12, 2010
Effect of anaesthesia maintained with sevoflurane and propofol on surgical site infection after elective open gastrointestinal surgeryK Shimizu, M Hirose, S Mikami, et al.
Journal of Gastroenterology|July 11, 1998
Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancerA Yamaguchi, T Goi, S Taguchi, et al.
Gynecologic Oncology|January 1, 1997
The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancerK Shimabukuro, N Toyama-Sorimachi, Y Ozaki, et al.
Oncology Reports|May 25, 2011
Sialyl-lewis-x antigen immunoreaction of colorectal-cancer and its relationship to hematogenous metastasisA Yamaguchi, M Saitoh, T Goi, et al.
Oncology|September 10, 1998
Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resectionA Yamaguchi, T Goi, K Seki, et al.
Pageof 3